| Nov 21 |
Why Is Cytokinetics, Incorporated (CYTK) Among the Worst Performing Biotech Stocks in 2024?
|
| Nov 20 |
Bayer Acquires Rights for Cardiovascular Drug From CYTK in Japan
|
| Nov 19 |
Cytokinetics and Bayer partner to develop for aficamten in Japan
|
| Nov 19 |
Astellas application rejected by FDA; Cytokinetics strikes licensing deal with Bayer
|
| Nov 19 |
Cytokinetics and Bayer Partner to Expand Aficamten's Reach in Japan
|
| Nov 19 |
Cytokinetics Will Get More Revenue for Marketing Aficamten in Japan
|
| Nov 19 |
Bayer acquires rights to Cytokinetics' heart drug in Japan
|
| Nov 19 |
Cytokinetics and Bayer Announce Exclusive Licensing Collaboration for Aficamten in Japan
|
| Nov 16 |
Cytokinetics Presents New Data Relating to Aficamten and Hypertrophic Cardiomyopathy at the American Heart Association Scientific Sessions 2024
|
| Nov 16 |
Cytokinetics Presents Additional Data From GALACTIC-HF at the American Heart Association Scientific Sessions 2024
|
